AstraZeneca’s new weight-loss pill, AZD5004, shows promise in early trials with tolerable side effects, advancing to Phase II studies focused on reducing obesity.
AstraZeneca reported on Monday that its experimental weight-loss pill, AZD5004, licensed from China's Eccogene for up to $2 billion, was found safe and tolerable in an early-stage trial.
The study, which included 72 participants who were either healthy or had type 2 diabetes, showed side effects consistent with other GLP-1 drugs, such as nausea and vomiting. Based on these findings, AstraZeneca has advanced AZD5004 to Phase II trials focused on weight reduction in overweight and obese individuals, with completion expected by late 2025.
Unlike injectable treatments from competitors Eli Lilly and Novo Nordisk, AZD5004 is a small molecule pill that can be combined with other medications and taken with or without food, offering potential advantages for patients with additional health conditions.
AstraZeneca also shared early-stage data on other obesity drugs, AZD6234 and AZD9550, which target different hunger-related hormones and will undergo further Phase II testing through 2026.
Meanwhile, Viking Therapeutics released early trial results for its own oral obesity drug, which briefly boosted its stock before a decline.
Massive crowds are gathering in the streets of Tehran on Monday for the funeral procession of Iran's slain former supreme leader, Ali Khamenei, as ...
Pakistan is seeking fresh Turkish investment after Prime Minister Shehbaz Sharif and President Recep Tayyip Erdoğan agreed to deepen economic coopera...
Burglars have stolen jewellery worth several million euros in a lightning raid on the Musée Lalique in eastern France, less than a year after a high-...
A groundbreaking study presented at ASCO reveals that AstraZeneca’s experimental pill camizestrant, when used based on blood test results, can halve the risk of breast cancer progression or death—potentially reshaping treatment for patients with hormone receptor-positive, HER2-negative breast cancer
AstraZeneca, opens new tab said it will spend $2.5 billion on a research and development hub in Beijing, as the drugmaker scrambles to revive business in its second-biggest market after scandals including the arrest of its China president last year.
The death toll from Venezuela's devastating twin earthquakes has risen to 3,342, according to the country's information ministry, as rescue teams continue searching affected areas and survivors face an uncertain recovery.
Mexico's national football team has returned luxury Rolex watches gifted by American content creator Stevewilldoit after concerns that they could conflict with FIFA's ethics rules.
Governments are tightening restrictions on teenagers’ use of social media amid growing concerns over mental health, online safety and platform design, but questions remain over enforcement and whether bans can meaningfully change behaviour.
President Donald Trump said Iran is keen to reach a deal with the United States, claiming Washington had paused engagement to allow funeral ceremonies for late Iranian Supreme Leader Ali Khamenei.
Thousands of mourners gathered in Tehran on Sunday as Iran held funeral prayers for Ayatollah Ali Khamenei and four members of his family on the second day of mass processions. Three of Khamenei's sons attended the ceremony, while his successor, Mojtaba Khamenei, made no public appearance.
More than 1,300 excess deaths have been recorded across Europe since June 21 as the continent faces extreme heat, World Health Organization Director-General Tedros Adhanom Ghebreyesus said.
The Central African Republic declared a cholera outbreak after 197 cases, including 24 deaths, were confirmed in two health districts southwest of the country’s capital Bangui, local media reported Saturday.
As France endures a record-breaking heatwave that has been linked to at least 40 drowning deaths, forecasters are using three key terms - pic de chaleur, vague de chaleur and canicule. Here's what they mean.
Australian authorities have expanded surveillance and testing efforts after confirming two cases of the highly pathogenic H5N1 bird flu, while neighbouring Papua New Guinea has suspended poultry imports from the country.
The United States has launched an investigation into Germany's pharmaceutical pricing policies to determine whether they unfairly disadvantage American companies and restrict U.S. commerce.
You can download the AnewZ application from Play Store and the App Store.
What is your opinion on this topic?
Leave the first comment